Henderson Jane sold APGE
December 4, 2025 · Form 4 insider transaction
Henderson Jane sold 1,500 shares of Apogee Therapeutics, Inc. at $75.00 per share, a transaction worth $112.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
1,500
Price
$75.00
Total value
$112.5K
InsiderHenderson Jane
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 4, 2025
Filing dateDecember 5, 2025
Shares owned after194,871
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 27, 2024.